| Financial Year |
March 31 2023 |
| Monetary Funds |
107,815,334.62 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,240,304.20 |
| Accounts Receivable |
30,093,360.21 |
| Advances to Suppliers |
338,019.35 |
| Other Receivables |
2,399,395.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
22,205,724.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
698,299.91 |
| Total Current Assets |
173,793,458.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
88,643,579.30 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
914,917.00 |
| Deferred Income Tax Assets |
2,106,699.94 |
| Other Non-Current Assets |
237,000.00 |
| Sub-Total of Non-Current Assets |
119,037,196.24 |
| Total Assets |
292,830,654.70 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
22,179,155.46 |
| Accounts Received In Advance |
454,172.55 |
| Employee Compensation Payable |
3,200,230.08 |
| Taxes Payable |
297,865.66 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,385,831.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
338,432.80 |
| Sub-Total of Current Liabilities |
38,579,253.83 |
| Long-term Loans |
14,733,249.22 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
15,658,249.22 |
| Total Liabilities |
54,237,503.05 |
| Paid-In Capital(Or Share Stock) |
280,253,733.00 |
| Capital Surplus |
1,705,277,310.44 |
| Surplus Reserve |
15,914,923.20 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,762,852,814.99 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
238,593,151.65 |
| Owner's Equity（Stockholder's Equity） |
238,593,151.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
292,830,654.70 |
